Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine for Hemodynamic Maintenance in Cesarean Delivery
NCT05264870Phase 4Terminated
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of norepinephrine in hypotension (2 arms). Primary endpoint: Dose of norepinephrine used. Started Jun 2022; status: terminated.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05264870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264870.